PROPHARMA
LIVE

Serial Number

87565861

Owner

PROPHARMA GROUP HOLDINGS, LLC

Attorney

Cheryl L. Burbach

Filing Date

Aug 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PROPHARMA Trademark

Serial Number: 87565861 • Registration: 5522690

PROPHARMA is a trademark filed by PROPHARMA GROUP HOLDINGS, LLC on August 11, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PROPHARMA GROUP HOLDINGS, LLC (18 trademarks)

OVERLAND PARK, KS 66210

Entity Type: 16

Trademark Details

Filing Date

August 11, 2017

Registration Date

July 24, 2018

Published for Opposition

February 6, 2018

Goods & Services

Regulatory compliance consulting in the pharmaceutical, biotechnology, and medical fields; Regulatory compliance consulting in the fields of drug and device development and manufacturing; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for legal or regulatory compliance purposes; Tracking and monitoring regulatory requirements in the field of drug and device development and manufacturing for regulatory compliance purposes

Providing quality assurance services in the medical, pharmaceutical, and biotechnology fields; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the medical, pharmaceutical, and biotechnology fields; Testing, analysis, and evaluation of medical, pharmaceutical, and biotechnology services to assure compliance with industry standards; Tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for quality control purposes

Business information and business consulting services, namely, providing business advisory services to identify, screen, and select contract manufacturing organizations to contract and build medical and pharmaceutical products and devices; providing business advisory services to health care providers, namely, designing the administrative, financial and clinical workflows associated with value-based healthcare delivery models; providing business assistance to healthcare providers in the field of enabling communication and collaboration for the purpose of developing, implementing and evaluating patient care plans; Business services, namely, tracking and monitoring regulatory requirements in the pharmaceutical, biotechnology, and medical fields for business purposes

Consulting services in the medical, pharmaceutical, and biotechnology fields; providing medical and pharmaceutical information services, namely, drug interaction call centers, adverse event reporting services for drugs and medical devices and product compliant reporting services for drugs and medical device; medical information; providing medical information, consultancy and advisory services; health care consulting, namely, aggregating clinical, claims, socioeconomic and behavioral health data for the purpose of improving healthcare providers' evaluation of health conditions and health risks with individual patients, cohorts of patients, and populations; health care consulting, namely, assessing patient and population health profiles using evidence-based medical guidelines for the purpose of improving healthcare provider treatment decisions at the point of care; providing information over a global computer network in the field of health care; maintaining files and records concerning the medical condition of individuals; maintaining personal medical history records and files; providing medical information, consultancy, and advisory services, namely, providing healthcare providers, insurance companies, and healthcare product manufacturers with information and statistics regarding patient medication intake, schedule compliance, and health status

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 23, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 23, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 23, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 23, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 23, 2025 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 25, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 25, 2024 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 25, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Aug 2, 2023 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 24, 2023 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 24, 2018 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Jun 17, 2018 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Feb 21, 2018 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 30, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 30, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 30, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 30, 2017 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 28, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 28, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 15, 2017 GNRN
NON-FINAL ACTION E-MAILED
Nov 15, 2017 GNRT
NON-FINAL ACTION WRITTEN
Nov 15, 2017 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2017 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Aug 31, 2017 AMPX
ASSIGNED TO LIE
Aug 31, 2017 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 18, 2017 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Aug 15, 2017 PARI
NEW APPLICATION ENTERED
Aug 15, 2017 NWAP